Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
colorectal cancer
Jun 14, 2024, 15:41 |
Blog
Wafik S. El-Deiry: Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway
Wafik S. El-Deiry shared a post on X: “Pleased to share published paper: Dopamine pre-treatment impairs…
Jun 12, 2024, 01:33 |
Insight
Upfront resection versus no resection of the primary tumor in patients with synchronous mCRC - Julius Center Research Program Cancer
Julius Center Research Program Cancer shared a post on LinkedIn: …
Jun 10, 2024, 11:27 |
Cancer Types
Primary Peritoneal Cancer: What patients should know about
Primary peritoneal cancer (PPC) is a rare and aggressive malignancy that originates in the peritoneum,…
Jun 9, 2024, 08:07 |
Blog
Ashley Magargee: I am so proud that Genentech is part of the Biden Cancer Moonshot program
Ashley Magargee, Chief Executive Officer at Genentech, shared a post by Genentech on LinkedIn: "We…
Jun 8, 2024, 11:07 |
Insight
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
MD Anderson researchers share preliminary clinical data of an antibody-drug conjugate for metastatic colorectal cancer…
Jun 8, 2024, 06:59 |
Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
Jun 8, 2024, 06:02 |
Insight
Cue Biopharma Presents Updated Data from CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the ASCO24
Cue Biopharma, a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively…
Jun 7, 2024, 09:11 |
Insight
Results of the NICHE-2 study by Myriam Chalabi - The Netherlands Cancer Institute
The Netherlands Cancer Institute (NKI) shared on X: "More success for neoadjuvant immunotherapy: results of…
Jun 7, 2024, 08:54 |
Insight
Andrew Allen: What an exciting time to be in the field of personalized cancer vaccines
Andrew Allen, President, CEO and Co-Founder at Gritstone Bio, recently shared on LinkedIn: "Cancer immunotherapy…
Jun 5, 2024, 10:23 |
Blog
Khalid El Bairi: The 2024 Conquer Cancer, the ASCO Foundation IDEA awardees wrote an article
Khalid El Bairi shared a post on X: "The 2024 Conquer Cancer, the ASCO Foundation IDEA…
18
19
20
21
22
All:
497
Posts:
191 - 200
Tsetsegsaikhan Batmunkh: Honored to be nominated for the board of directors of the UICC
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube